发明名称 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
摘要 The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
申请公布号 US9453074(B2) 申请公布日期 2016.09.27
申请号 US201414254206 申请日期 2014.04.16
申请人 Baylor Research Institute 发明人 Oh Sangkon;Li Dapeng
分类号 A61K39/00;A61K39/395;A01N63/00;C07K16/28;A61K47/48;A61K51/10;C07K14/005;C07K14/195;C07K14/37;C07K14/405;C07K14/435 主分类号 A61K39/00
代理机构 Norton Rose Fulbright US LLP 代理人 Norton Rose Fulbright US LLP
主权项 1. A method for increasing the effectiveness of antigen presentation by dendritic cells in an individual comprising the steps of: attaching ex vivo a dendritic cell asialoglycoprotein receptor (DC-ASGPR)-specific antibody or DC-ASGPR-specific fragment thereof to an antigen to form an antibody-antigen complex, wherein the antigen is an autoantigen; and delivering an effective amount of the complex to the individual, wherein the antigen is processed and presented by a dendritic cell that has been contacted with the antibody-antigen complex, wherein the antibody or fragment thereof comprises an immunoglobulin heavy chain selected from the group consisting of SEQ ID NO: 5, 7, 9, or 11, wherein the antibody or fragment thereof targets a human DC-ASGPR.
地址 Dallas TX US
您可能感兴趣的专利